跳至主要内容
临床试验/NL-OMON21471
NL-OMON21471尚未招募不适用

Correlation between endogenous DPD substrate concentrations and the pharmacokinetics and toxicity of 5-fluorouracil in patients with colorectal or pancreas cancer

Catharina Hospital Eindhoven0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational non invasive

入排标准

入选标准

  • 1. Pathologically confirmed malignancy for which treatment with 5-FU is indicated in the FOLFOX, FOLFIRI or FOLFIRINOX regimen.
  • 2. Age = 18 years
  • 3. Able and willing to give written informed consent
  • 4. WHO performance status 0-2
  • 5. Minimal acceptable safety laboratory values defined as
  • a. ANC of = 1.5 x 109 /L
  • b. Platelet count of = 100 x 109 /L
  • c. Hepatic function as defined by serum bilirubin = 1.5 x ULN, ALAT and ASAT = 2.5 x ULN; in case of liver metastases ALAT and ASAT = 5 x ULN.
  • d. Renal function as defined by MDRD >30 mL/min

排除标准

  • 1. Patients with known substance abuse, psychotic disorders, and/or other diseases expected to interfere with study or the patient’s safety
  • 2. Women who are pregnant or breast feeding
  • 3. Patients in whom the bolus injection will be skipped due to e.g. toxicity of previous chemo therapy regimen.

研究者

发起方
Catharina Hospital Eindhoven

相似试验

Correlation between endogenous DPD substrate... | 临床试验